Kloub Mohammad, Pati Shefali, Haddad Ahmad W, Abu Ruman Yazeed, Al-Maharmeh Qusai, Rayad Mohammad Nabil, Tewoldemedhin Bereket, Slim Jihad
Department of Internal Medicine, Saint Michael's Medical Center, Newark, USA.
Department of Internal Medicine, St George's University, True Blue, GRD.
Cureus. 2025 Mar 24;17(3):e81110. doi: 10.7759/cureus.81110. eCollection 2025 Mar.
infection (CDI), characterized by diarrheal illness with serious complications, is a common pathology in clinical practice. We present a series of five patients with CDI who underwent treatment with fidaxomicin following the failure of oral vancomycin. To our knowledge, no evidence in the literature suggests that fidaxomicin is more effective than vancomycin in treating acute infection. This paper emphasizes the importance of utilizing a large study to determine the relative effectiveness of vancomycin versus fidaxomicin in treating CDI. We also provide a literature review on CDI and management evolution.
艰难梭菌感染(CDI)以伴有严重并发症的腹泻病为特征,是临床实践中一种常见的病理情况。我们报告了5例艰难梭菌感染患者,他们在口服万古霉素治疗失败后接受了非达霉素治疗。据我们所知,文献中没有证据表明非达霉素在治疗急性艰难梭菌感染方面比万古霉素更有效。本文强调了开展大型研究以确定万古霉素与非达霉素治疗艰难梭菌感染相对有效性的重要性。我们还提供了一篇关于艰难梭菌感染及其管理演变的文献综述。